SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A POS -
SEC Accession No. 0001104659-20-126360
Filing Date
2020-11-17
Accepted
2020-11-17 16:15:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A POS  
1 primary_doc.xml 1-A POS 17391
2 PART II AND III tm2024664-10_1apos.htm PART II AND III 2076859
3 EXHIBIT 11.1 tm2024664d10_ex11-1.htm EX1A-11 CONSENT 2482
4 GRAPHIC lg_scopus-pn.jpg GRAPHIC 2106973
  Complete submission text file 0001104659-20-126360.txt   4483847
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A POS | Act: 33 | File No.: 024-11228 | Film No.: 201321301
SIC: 2834 Pharmaceutical Preparations